Following vascular changes in children from type 1 diabetes diagnosis
Studies how and when blood vessel damage develops in children with type 1 diabetes.
Plain-language title generated from the registry record
Registry title: Vascular Complications in Children From T1D Diagnosis
Key facts
- Where
- Vancouver, CanadaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 8 and 18 years old?
Source: NCT05790785, who can take part
Where in Canada
- Endocrine and Diabetes Unit, BC Children's HospitalVancouver, CanadaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of British Columbia
- Trial code
- NCT05790785
- Record updated
- 2 May 2025
- Original description
Cardiovascular disease is a complication of type 1 diabetes (T1D), a life-long disease, usually diagnosed in childhood. The goal of this project is to determine the timing and factors leading to vascular damage in children from T1D diagnosis.Read full original descriptionShow less
Understanding Vascular Complications in Children From Type 1 Diabetes Diagnosis
Cardiovascular disease is a complication of type 1 diabetes (T1D), a life-long disease, usually diagnosed in childhood. The goal of this project is to determine the timing and factors leading to vascular damage in children from T1D diagnosis.
Inclusion: Between the ages of 8-18 years; Within 14 weeks of type 1 diabetes diagnosis; Ability and willingness to undergo non-invasive arterial stiffness assessment for 1hr and willingness to wear the 24-h automated blood pressure monitoring (ABPM) device.
Exclusion: Transgender children taking hormone blockers or exogenous sex steroids; Currently treated with medications known to affect metabolism (e.g. glucocorticoids, antipsychotics); Other cardiometabolic or endocrine diseases diagnosis (type 2 diabetes; familial disorders of cholesterol metabolism; lupus); Other genetic syndromes (Down Syndrome; Prader-Willi); Eating disorder diagnosis; Children will be ineligible to participate in the study if they meet any of the following:.